3 research outputs found

    CABINET OF A HEALTHY CHILD IN THE CONTEXT OF HEALTH CARE REFORM

    No full text
    One of the key tasks of the childrenā€™s polyclinic is the prevention of childhood diseases. This issue is devoted to many studies, whichĀ  unfortunately suggest a weakening of preventive positions in recent years. Increase level requirements for the provision of primaryĀ  health care for childrenā€™s population and priority prevention areas leads to the increase of the role of the room of a healthy child, andĀ  necessitates changes in the organization of work and equipping of this unit.Ā  Based on the existing laws and regulations and modern ideas about the key role of a room of healthy child in the preventive workĀ  and maintenance of childrenā€™s health, we have developed and submitted proposals on optimization of work of this departmentĀ  of the childrenā€™s clinic

    THE PARATHYROID HORMONE LEVEL AND ITS CORRELATION WITH THE SUPPLY OF VITAMIN D IN EARLY CHILDHOOD

    Get PDF
    The literature data and the finding of our studies on the analysis of the correlation between the level of parathyroid hormone and supply of vitamin D of children (n=107) of early age are presented in the article.The serum level of vitamin D in the analyzed group of children was 24.8 [17.6ā€“32.5] ng/ml, the median of the parathyroid hormoneĀ  was 21.0 [12.3ā€“25.5] pg/ml. It has been established that children with optimal supply of vitamin D have significantly lower parathyroid hormone levels vs. the children with vitamin D insufficiency (25 (OH) D from 20 to 30 ng/ml) and deficiency (calcidiol valuesĀ  below 20 ng/ml). The correlation between the level of vitamin D and parathyroid hormone was r=-0.18, p=0.035.The best supply of vitamin D was found in children of the first year of life ā€“ 25 (OH) D concentration was 29.95 [16.2ā€“40.3] ng/ml.Ā  The parathyroid hormone level (16.5 [10.7ā€“23.8] pg/ml) in these children was reliably lower (p=0.05) vs. the children of the secondĀ  and third years of life. A positive correlation was established between the age of patients and the parathyroid hormone level (r=0.2,Ā  p=0.05). Preventive doses of vitamin D were received by 42.1% of children. The blood serum concentration of 25 (OH) D in themĀ  was higher (32.7 ng/ml), and the parathyroid hormone level was significantly lower (14.9 pg/ml) vs. the children who did not receiveĀ  cholecalciferol preparations (p<0.05).The obtained results demonstrate a strong correlation between vitamin D deficiency and the increased parathyroid hormone level that reflectĀ  the importance of these hormones in the regulation of calcium-phosphorus metabolism and the opposite role in bone tissue calcification

    EFFICIENCY OF PREVENTION AND MANAGEMENT OF VITAMIN D DEFICIENCY IN YOUNG CHILDREN IN RUSSIA DEPENDING ON THE REGION OF RESIDENCE (BASED ON THE RESULTS OF RODNICHOK-2 STUDY)

    Get PDF
    Medical examination of 360 children from four regions of Russia (Moscow, Astrakhan, Stavropol, Kazan) showed significant regional differences in the sufficiency and compensation of vitamin D deficiency at the baseline (Day 0) and established factors associated with vitamin D sufficiency on Day 0. The established interregional differences in vitamin D levels were not due to insolation, but primarily to adequate vitamin D supplementation received at the baseline. Vitamin D supplementation (an average of 894 Ā± 632.6 IU/day) significantly reduced the risk of vitamin D deficiency (RR 0.15, 95% CI 0.09ā€“0.26, P = 5.7 x 10ā€“14). The study included the analysis of factors associated with the increase in 25(OH)D levels during the administration of Aquadetrim, identification of predictors of patientā€™s response and the analysis of identified predictors. The most important factor determining the patientā€™s response was the dose of vitamin D taken by the patient: 25(OH)D levels increased by 1 ng/ml with an increase in the dose of vitamin D by 90 IU per day. As can be seen from the above, the study results indicate that the vitamin D deficiency requires a long-term preventive therapy (for at least several months) with adequate doses of vitamin D (1000ā€“2000 IU/day)
    corecore